Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2010
05/26/2010CN101125886B Method for extracting yolk immunoglobulin
05/25/2010US7723566 Regeneration
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders
05/25/2010US7723490 Process for correction of a disulfide misfold in Fc molecules
05/25/2010US7723489 blocking the binding of thyrotropin with a receptor; treating hyperthyroidism, Graves' disease ophthalmopathy
05/25/2010US7723488 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders
05/25/2010US7723487 Method for purifying cancer-specific proliferating cell nuclear antigen
05/25/2010US7723486 antibody that binds to human TGF beta 1, TGF beta 2 and TGF beta 3, comprising the PET1073G12 heavy chain variable domain (SEQ ID NO: 2) and the PET1073G12 light chain variable domain (SEQ ID NO: 7), or an isolated segment of the antibody
05/25/2010US7723485 Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
05/25/2010US7723483 An antibody binding to the cysteine loop domain at amino acids 177-184 of a human or pig beta 3 integrin (Amino Acid SEQ ID NO: 82); does not bind to the RGD binding site of a human beta 3 integrin or utilize the RGD binding site of human beta 3 integrin; side effect reduction; nontoxic
05/25/2010US7723482 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723477 Frizzled receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
05/25/2010US7723298 Cytokine receptor
05/25/2010US7723270 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering
05/25/2010US7723269 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
05/25/2010US7723080 Murine α (1,3) fucosyltransferase Fuc-TVII, DNA encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such DNA, and cells containing such a plasmid
05/25/2010US7723073 Nucleic acid sequences containing a coding sequence for a light chain of an anti-VLA-1 antibody or antigen binding fragment, and a coding sequence for a heavy chain of an anti-VLA-1 antibody or fragment; the light chain and the heavy chain form an antibody or fragment that binds VLA-1
05/25/2010US7723043 applying a body-fluid sample to a solid phase immunoassay device comprising an anti-GPC3 antibody, quantifying the level of Glypican-3 (GPC3) protein in the sample
05/25/2010US7723042 Using parathyroid receptor epitope binding activity as a diagnostic indicator concentration of parathyroid hormone; diagnosing hyper/hypo-parathyroidism
05/25/2010US7722886 Therapeutic agent comprising cytokine inhibitory activity for use in treatment of respiratory system disorders; viricides; antisense agents; enzyme inhibitors; immunotherapy; RNA interference; recombinant cytokine receptors
05/25/2010US7722879 amino acid sequence proteins or immunogenic fragments, encoded sequence from isolated nucleic acid; for treating infection caused from Babesiidae; diagnostic test for the detection of nucleic acids, antibodies or antigens of the organism; safe, stable, easily scaleable production; veterinary medicine
05/25/2010US7722876 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity
05/25/2010US7722875 Antibodies that bind canine pancreatic lipase
05/25/2010US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells
05/25/2010US7722872 Treatment of cancer with antibodies to costimulating polypeptide of T cells
05/25/2010US7722871 Immunoglobulins devoid of light chains
05/25/2010US7722870 Method of treating fibroproliferative disorders
05/25/2010US7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof
05/25/2010US7722867 Nucleotide sequences coding chimeric immunoglobulin specific for epidermal growth factor receptor; treatment and prevention of cell proliferative disorders
05/25/2010US7722866 using a monoclonal antibody or an antigen-binding portion which binds to an epitope of EphB4 polypeptide and inhibiting the growth of cancer as a result of such binding by causing cell death
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2354928C Non-mucin type synthetic compounds or it's carrier conjugated compounds
05/25/2010CA2313248C Process for the production of naturally folded and secreted proteins by co-secretion of molecular chaperones
05/25/2010CA2241786C Novel amp activated protein kinase
05/25/2010CA2225189C Canine factor viii gene, protein and methods of use
05/25/2010CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions
05/25/2010CA2199715C Novel implant and novel vector for the treatment of acquired diseases
05/20/2010WO2010057175A1 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
05/20/2010WO2010057047A1 Cd37 immunotherapeutic combination therapies and uses thereof
05/20/2010WO2010056966A2 Novel hiv-2 isolate
05/20/2010WO2010056948A2 Humanized anti-il-6 antibodies
05/20/2010WO2010056898A2 Rapid expression cloning of human monoclonal antibodies from memory b cells
05/20/2010WO2010056893A1 Humanization and affinity-optimization of antibodies
05/20/2010WO2010056816A2 βGI-IGG INTRON FOR ENHANCED ANTI-IGF1 R EXPRESSION
05/20/2010WO2010056804A1 Antibody formulation
05/20/2010WO2010056796A1 Human m2e peptide immunogens
05/20/2010WO2010056550A1 Methods for purification of single domain antigen binding molecules
05/20/2010WO2010056399A1 Method and composition for modulating the immune system and various inflammatory conditions comprising complement depletors
05/20/2010WO2010056043A2 Cell-penetrating, sequence-specific and nucleic acid-hydrolyzing antibody, method for preparing the same and pharmaceutical composition comprising the same
05/20/2010WO2010055867A1 Method for determining therapeutic effect of reperfusion therapy
05/20/2010WO2010055525A1 Method for predicting a patient's responsiveness to anti-folate therapy
05/20/2010WO2010037027A3 Immunization of avians by mucosal administration of non-replicating vectored vaccines
05/20/2010WO2010035259A3 Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
05/20/2010WO2010032008A3 Dendritic cell modulatory molecule
05/20/2010WO2010025321A3 Method for treating multiple sclerosis patients with anti-il2r antibodies
05/20/2010WO2010009987A3 Diagnostic antibody assay
05/20/2010WO2009151717A3 Bcr-complex-specific antibodies and methods of using same
05/20/2010US20100125131 Gene Encoding A Guanine Nucleotide Exchange Factor And The Gene Product Thereof
05/20/2010US20100125130 Tumour necrosis factor binding ligands
05/20/2010US20100125127 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation
05/20/2010US20100124556 Novel shigella protein antigens and methods
05/20/2010US20100124555 Compositions and Methods for Treating Pancreatic Tumors
05/20/2010US20100124553 Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy
05/20/2010US20100124552 Peptide biomarkers of cardiovascular disease
05/20/2010US20100124551 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
05/20/2010CA2743853A1 Novel hiv-2 isolate
05/20/2010CA2743775A1 .beta.gi-igg intron for enhanced anti-igf1r expression
05/20/2010CA2743590A1 Diagnosis of multiple sclerosis
05/20/2010CA2743487A1 Cd37 immunotherapeutic combination therapies and uses thereof
05/20/2010CA2743469A1 Antibody formulation
05/20/2010CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010CA2743306A1 Human m2e peptide immunogens
05/20/2010CA2742786A1 Humanized anti-il-6 antibodies
05/20/2010CA2739352A1 Methods for purification of single domain antigen binding molecules
05/20/2010CA2738789A1 Process for the purification of antibodies using affinity resins comprising specific ligands
05/20/2010CA2707026A1 Anti-human il-21 monoclonal antibodies
05/19/2010EP2187217A1 Detection method of gynecologic cancer
05/19/2010EP2187216A1 Novel liver cancer marker
05/19/2010EP2186896A1 Cancer antigen peptides derived from WT1
05/19/2010EP2186894A1 Monoclonal antibody having neutralizing activity against mmp13
05/19/2010EP2186893A1 Production and use of epitope-tagged hepatitis c virus particle
05/19/2010EP2186892A1 Anti-cd20 monoclonal antibodies
05/19/2010EP2186888A1 Transgenic non-human animals capable of producing heterologous antibodies
05/19/2010EP2186884A2 HCV-anti-core monoclonal antibody
05/19/2010EP2186829A1 Antibodies against GPIbalpha
05/19/2010EP2186827A1 Surrogate marker directed cDNA cloning of selectively induced mRNAs
05/19/2010EP2186820A1 Protein-protein interactions in human immunodeficiency virus
05/19/2010EP2186527A1 Compositions comprising polypeptides
05/19/2010EP2185933A2 Matriptase protein and uses thereof
05/19/2010EP2185719A2 Anti-rantes antibodies and methods of use thereof
05/19/2010EP2185688A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
05/19/2010EP2185595A1 Recombinant, single-chain, trivalent tri-specific or bi-specific antibody derivatives
05/19/2010EP2185594A1 Cancer treatment using humanized antibodies that bind to ephb4
05/19/2010EP2185593A1 Methods and compositions for treating autoimmune disease
05/19/2010EP2185592A1 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
05/19/2010EP2185591A1 Production method
05/19/2010EP2185590A2 Methods for recombinant manufacturing of anti-rsv antibodies
1 ... 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 ... 1494